Zacks Investment Research
02 Feb 2026, 18:00 UTC · 40w ago
Impact · against what's priced in
The upgrade of Verrica Pharmaceuticals to a Zacks Rank #1 suggests improving earnings expectations that may trigger near-term buying pressure. Other mentioned tickers are merely listed as high-traffic stocks, which is not material to their fundamental valuations.
No priced-in read yet
What the story claims
1 claim · scored −1 bearish … +1 bullish
Verrica Pharmaceuticals (VRCA) has been upgraded to a Zacks Rank #1 (Strong Buy).
So whatA top-tier rating based on upward earnings estimate revisions typically signals positive near-term price action and institutional buying pressure.
More positive than 77% of claims this week
Which stocks this story touches
Continue reading
5 related stories
The upgrade to a Strong Buy reflects a positive trend in earnings estimate revisions, which historically correlates with near-term price increases.
Read from the article alone
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 98% of ticker scores this week
The company received a Zacks Rank #1 (Strong Buy) upgrade due to an upward trend in earnings estimates.
More positive than 48% of ticker scores this week
Listed as a top-viewed stock, suggesting high investor interest.
More positive than 48% of ticker scores this week
Listed as having significant page view growth, suggesting increasing investor interest.
More positive than 48% of ticker scores this week
Listed as a top-viewed stock, suggesting high investor interest.
More positive than 48% of ticker scores this week
Listed as having significant page view growth, suggesting increasing investor interest.
More positive than 48% of ticker scores this week
Listed as having significant page view growth, suggesting increasing investor interest.
More positive than 48% of ticker scores this week
Listed as having significant page view growth, suggesting increasing investor interest.
More positive than 48% of ticker scores this week
Listed as a top-viewed stock, suggesting high investor interest.
More positive than 48% of ticker scores this week
Listed as having significant page view growth, suggesting increasing investor interest.
More positive than 48% of ticker scores this week
Listed as having significant page view growth, suggesting increasing investor interest.
More positive than 48% of ticker scores this week
Listed as a top-viewed stock, suggesting high investor interest.
More positive than 48% of ticker scores this week
Listed as a top-viewed stock, suggesting high investor interest.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
1h ago
−47.1%
Price is moving against the score
$3.72 vs $7.03 close before publication (Jan 30) · not market-adjusted
VRCA chart →
